PGP and cancer: The increased efflux of hydrophobic drugs from the cell by ATP-binding cassette (ABC) transporter trans-membrane proteins such as p-glycoprotein (p-gp, also known as MDR1) results in a prevention of drug accumulation, thus reducing the sensitivity of cancer cells to anticancer drugs [3].